Clinical Research, Pharma & Healthcare FinancingHumanetics Chooses Lifecore for BIO 300 CDMO ServicesGlobeNewswireMarch 18, 2025August 1, 2025 by GlobeNewswireMarch 18, 2025August 1, 20250121 Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM) Lifecore to Carry Out Tech Transfer and Analytical...
